SELLAS Life Sciences Group (NASDAQ: SLS) presented preclinical data at the American Association for Cancer Research Conference on Pancreatic Cancer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE